Belgüzar Kara1. 1. Diyarbakir Military Hospital, Diyarbakir, Turkey. sb.kara@mynet.com
Abstract
AIM: To examine herbal product use among patients with end-stage renal disease undergoing haemodialysis. BACKGROUND: Herbal therapy is a very popular choice for many patients. However, little information is available about herbal product use in renal patients. DESIGN: The study was designed as a cross-sectional survey. The data were obtained from 114 end-stage renal disease patients in two haemodialysis centres in Ankara, Turkey between June-August 2007. METHODS: Data were collected through face-to-face structured interviews. Descriptive statistics and the chi-square test were conducted. RESULTS: Approximately one-third of the patients (28.1%) used a herbal product after the diagnosis of chronic kidney disease. Of these, 13.2% reported currently taking herbal products. A minority of participants (12.5%) informed their physician of herbal product use. Marital status was the only variable significantly associated with herbal product use. CONCLUSIONS: The results of this study showed that many patients used herbal products, but most did not disclose this use to their physician. Herbal product use was more prevalent among the participants who were married. RELEVANCE TO CLINICAL PRACTICE: Understanding the patterns and reasons of herbal use is beneficial in efforts to improve the care of patients with end-stage renal disease. Nurses should be aware of the potential health risks caused by herbal products and should educate the patient and the family.
AIM: To examine herbal product use among patients with end-stage renal disease undergoing haemodialysis. BACKGROUND: Herbal therapy is a very popular choice for many patients. However, little information is available about herbal product use in renal patients. DESIGN: The study was designed as a cross-sectional survey. The data were obtained from 114 end-stage renal diseasepatients in two haemodialysis centres in Ankara, Turkey between June-August 2007. METHODS: Data were collected through face-to-face structured interviews. Descriptive statistics and the chi-square test were conducted. RESULTS: Approximately one-third of the patients (28.1%) used a herbal product after the diagnosis of chronic kidney disease. Of these, 13.2% reported currently taking herbal products. A minority of participants (12.5%) informed their physician of herbal product use. Marital status was the only variable significantly associated with herbal product use. CONCLUSIONS: The results of this study showed that many patients used herbal products, but most did not disclose this use to their physician. Herbal product use was more prevalent among the participants who were married. RELEVANCE TO CLINICAL PRACTICE: Understanding the patterns and reasons of herbal use is beneficial in efforts to improve the care of patients with end-stage renal disease. Nurses should be aware of the potential health risks caused by herbal products and should educate the patient and the family.
Authors: Aravapalli S M Arjuna Rao; D Phaneendra; Ch Divya Pavani; P Soundararajan; N Vanitha Rani; P Thennarasu; G Kannan Journal: J Pharm Bioallied Sci Date: 2016 Jan-Mar